UTMB Researchers Target Improved Locomotor Functions in Subjects With Spinal Cord Injuries
October 16, 2024
October 16, 2024
GALVESTON, Texas, Oct. 16 (TNSres) -- The University of Texas Medical Branch issued the following news release:
Using bumetanide, a diuretic drug already approved by the Food and Drug Administration, researchers at the University of Texas Medical Branch were able to protect excitatory neurons from the damage caused by long-term swelling in spinal cord injuries.
The researchers administered bumetanide to mice with spinal cord injuries, which resulted in improved recovery . . .
Using bumetanide, a diuretic drug already approved by the Food and Drug Administration, researchers at the University of Texas Medical Branch were able to protect excitatory neurons from the damage caused by long-term swelling in spinal cord injuries.
The researchers administered bumetanide to mice with spinal cord injuries, which resulted in improved recovery . . .